M

Mursla

15 employees

Nextgen multi-omics liquid biopsy and precision medicine tests via tissue-specific extracellular vesicles

Basic info

Industry

biotechnology research

Sectors

Biotechnology
techbio
cancer
extracellular vesicle
proteomics
biology
Health Diagnostics
transcriptomics
Information Technology
oncology
biomarker
Medical Device
computational biology
liquid biopsy
diagnostics
liver
Internet of Things
biotech

Date founded

2019

Funding rounds raised

M

Mursla raised undisclosed on March 30, 2022

Investors: Greater London Authority

FAQ